Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in limited-stage small-cell lung cancer: A meta-analysis

S Zhang, Y Wang, Y Cheng - Future Oncology, 2023 - Taylor & Francis
Background: The role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte
ratio (PLR) as prognostic markers in limited-stage small-cell lung cancer (LS-SCLC) remains …

Machine learning for identifying benign and malignant of thyroid tumors: A retrospective study of 2,423 patients

Y Guo, Z Li, C Du, J Gong, P Liao, J Zhang… - Frontiers in Public …, 2022 - frontiersin.org
Thyroid tumors, one of the common tumors in the endocrine system, while the discrimination
between benign and malignant thyroid tumors remains insufficient. The aim of this study is to …

The diagnostic and prognostic value of haematologic parameters in multiple myeloma patients

F Han, N Sheng, C Sheng, J Meng - Hematology, 2023 - Taylor & Francis
Objectives Multiple myeloma (MM) is a malignant disease characterized by a single clonal
proliferation of B cell-derived plasma cells in the bone marrow. It is the second most …

The prognostic role of lymphocyte to monocyte ratio (LMR) in patients with Myelodysplastic Neoplasms

C Lu, Q Chen, J Li, C Wang, L Yu - Hematology, 2023 - Taylor & Francis
Background: Previous studies validated the prognostic significance of lymphocyte to
monocyte ratio (LMR) in patients with solid tumors and some hematologic malignancies …

Changes in Laboratory Indexes for Multiple Myeloma Patients Before and After Autologous Stem Cell Transplant

R Zhao, J Zhao, Y Song, W Fu, Q Wang… - Journal of Inflammation …, 2023 - Taylor & Francis
Purpose Outcomes after autologous stem cell transplantation (ASCT) are quite variable and
difficult to predict. Second-generation flow, second-generation sequencing, and other tests …

An elevated systemic inflammation index is related to an inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory …

D Mikulski, P Robak, G Mirocha, W Ryżewska… - Contemporary …, 2023 - termedia.pl
Results: The study group consisted of 54 patients. Most patients received Pd as the third
(38.9%) or fourth (37.0%) line of treatment. The median number of completed treatment …

LMR, PNI 与多发性骨髓瘤患者化疗反应及预后的关系

陈小双, 高正杰, 高攀科, 邢瑞, 韩效林, 李敬东 - 中华全科医学, 2023 - zhqkyx.net
目的探讨淋巴细胞单核细胞比值(LMR) 和预后营养指数(PNI) 对多发性骨髓瘤(MM)
患者化疗反应及预后的影响. 方法选取2016 年3 月—2022 年5 月新乡医学院第一附属医院收治 …

The combination of serum calcium levels, neutrophil‑to‑lymphocyte ratio and platelet count in the prognosis of multiple myeloma: A retrospective cohort study and …

MP Vu, VT Han, PT Pham, H Vu - World Academy of …, 2022 - spandidos-publications.com
The prognosis of multiple myeloma (MM) can be determined by the serum calcium levels,
the neutrophil‑to‑lymphocyte ratio (NLR) and the platelet count (PLT). The objective of the …

Biomarkeri inflamacije i ekstracelularne vezikule kao prediktori venske tromboembolije kod pacijenata sa limfomom

V Otašević - Универзитет у Београду, 2023 - nardus.mpn.gov.rs
Limfomi predstavljaju vrlo heterogenu grupu neoplazmi, čija se biološka raznolikost ogleda
u različitim mehanizmima napredovanja bolesti i razvoja komplikacija. Jedna od …

¿ Es el ratio neutrófilo/linfocito un marcador pronóstico en el trasplante alogénico de médula ósea?

L Quintana Bravo - 2023 - repositorio.unican.es
En este estudio nos preguntamos si el ratio neutrófilo linfocito (RNL) en el paciente que ha
recibido un trasplante alogénico hematopoyético (TPH) puede servir de pronóstico en la …